-
Human medicines European public assessment report (EPAR): Abraxane, paclitaxel, Date of authorisation: 11/01/2008, Revision: 31, Status: Authorised
30 Jan 2025 17:24 GMT
… the combination of Abraxane and gemcitabine, compared with 6.7 months … on gemcitabine alone.
In non-small cell lung cancer, 33% of …
-
Drug-Eluting Beads Bronchial Arterial Chemoembolization Combined with Immunotherapy Resulted in Pathological Complete Response of Squamous Cell Lung Cancer: A Case Report
18 Dec 2024 16:06 GMT
… candidate drug for treating lung cancer. Importantly, epirubicin … arterial chemoembolization in lung cancer patients with hemoptysis. … pathologic assessment of lung cancer resection specimens after … gemcitabine for treatment of non-small cell lung cancer. …
-
Verastem Oncology Provides a Clinical Update for RAMP 203 Trial in Advanced KRAS G12C Mutant Non-Small Cell Lung Cancer
18 Dec 2024 12:41 GMT
… mutant advanced non-small cell lung cancer (NSCLC). No dose-limiting … mutant non-small cell lung cancer.”
RAMP 203 Clinical Update … G12C mutant non-small cell lung cancer (NSCLC) who have … avutometinib and defactinib with gemcitabine/nab-paclitaxel in …
-
AstraZeneca's Imfinzi receives US FDA approval to treat patients with limited─stage small cell lung cancer
06 Dec 2024 04:06 GMT
… extensive-stage small cell lung cancer, underscoring our commitment … combination with chemotherapy (gemcitabine plus cisplatin) in … portfolio includes leading lung cancer medicines and the … improvements for people with lung cancer, including and beyond …
-
IMFINZI® (durvalumab) approved in the US as first and only immunotherapy regimen for patients with limited-stage small cell lung cancer
05 Dec 2024 12:23 GMT
… Notes
Small cell lung cancer
Lung cancer is the leading … combination with chemotherapy (gemcitabine plus cisplatin) in … for people with lung cancer, including and beyond … lung-cancer-101/types-of-lung-cancer.
American Cancer Society. Small cell lung cancer …
-
Pancreatic cancer: Oncolytics Biotech, Candel, and CytomX bring promising therapies to the clinic
29 Jan 2025 16:39 GMT
… will be second only to lung cancer in its lethality by 2025 … atezolizumab, and the chemotherapeutic agents gemcitabine and nab-paclitaxel, for the …
-
High-dose IV vitamin C doubles pancreatic cancer survival
29 Jan 2025 14:43 GMT
… be administered safely with gemcitabine for individuals with stage … to standard-of-care gemcitabine and nab-paclitaxel … adverse events common with gemcitabine and nab-paclitaxel treatment. … C in patients with lung cancer.
Other researchers have investigated …
-
Understanding Lung Cancer Stages And Making Informed Treatment Decisions
13 Nov 2024 13:54 GMT
… types of lung cancers are non-small cell lung cancer and small cell lung cancer. Dr … drugs used in lung cancer (NSCLC) are cisplatin, etoposide, carboplatin, gemcitabine, and paclitaxel …
-
Merck and Moderna Initiate Phase 3 Trial Evaluating Adjuvant V940 (mRNA-4157) in Combination with KEYTRUDA® (pembrolizumab) After Neoadjuvant KEYTRUDA and Chemotherapy in Patients With Certain Types of Non-Small Cell Lung Cancer (NSCLC)
28 Oct 2024 10:49 GMT
… lung cancer have significantly improved in recent years, lung cancer … -009.
About lung cancer
Lung cancer is the leading … lung cancer globally. Non-small cell lung cancer is the most common type of lung cancer … protein-bound, or gemcitabine and carboplatin) were …
-
Daraxonrasib Demonstrates Efficacy, Potential to Inhibit Major RAS(ON) Variants in RAS+ PDAC
28 Jan 2025 17:16 GMT
… choice of standard-of-care gemcitabine/nab-paclitaxel, modified FOLFIRINOX … (PDAC) and non-small cell lung cancer (NSCLC). Ann Oncol. 2023;34 …
About
© 1995-2025